In Reply

Affiliations

¹ Unité de Recherche clinique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), and Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, Paris, France.
² Obstetrics and Gynaecology Department, AP-HP, Antoine Béclère Hospital. Paris Saclay University, Clamart, France.
³ Department of Genomic Medicine for Rare Diseases, French Reference Center for Constitutional Bone Diseases, Necker-Enfants Malades Hospital, and Paris Cité University, INSERM UMR 1163, Imagine Institute, Paris, France.
⁴ Unité de Recherche clinique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, and Centre d'Investigation Clinique (CIC) 1419, Hôpitaux Cochin-Necker, Inserm, Paris, France.
⁵ Paris Cité University, INSERM UMR 1163, Imagine Institute, Paris, France.
⁶ Rheumatology Department, Cochin Hospital, AP-HP Centre-Paris University, and Reference Center for Rare Genetic Bone Disorders-Cochin-constitutive site, Cochin Hospital, Paris, France.

Mathis Collier et al. Obstet Gynecol. 2025.

. 2025 Dec 1;146(6):e109-e110.

doi: 10.1097/AOG.0000000000006104.

¹ Unité de Recherche clinique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), and Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, Paris, France.
² Obstetrics and Gynaecology Department, AP-HP, Antoine Béclère Hospital. Paris Saclay University, Clamart, France.
³ Department of Genomic Medicine for Rare Diseases, French Reference Center for Constitutional Bone Diseases, Necker-Enfants Malades Hospital, and Paris Cité University, INSERM UMR 1163, Imagine Institute, Paris, France.
⁴ Unité de Recherche clinique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, and Centre d'Investigation Clinique (CIC) 1419, Hôpitaux Cochin-Necker, Inserm, Paris, France.
⁵ Paris Cité University, INSERM UMR 1163, Imagine Institute, Paris, France.
⁶ Rheumatology Department, Cochin Hospital, AP-HP Centre-Paris University, and Reference Center for Rare Genetic Bone Disorders-Cochin-constitutive site, Cochin Hospital, Paris, France.

No abstract available

Conflict of interest statement

Financial Disclosure The authors did not report any potential conflicts of interest.

1. Chen R, Wang C, Li B. Oncologic outcomes of laparoscopic radical hysterectomy incorporating modified tumor-free techniques. Obstet Gynecol 2025;145:e145–6. doi: 10.1097/AOG.0000000000005894 - DOI
1. Collier M, Hannoun P, Cormier-Daire V, Treluyer J-M, Benachi A, Koumakis E. Pregnancy-related complications in osteogenesis imperfecta. Obstet Gynecol 2025 Jul 21 [epub ahead of print]. doi: 10.1097/AOG.0000000000005957 - DOI